Bi Asset Management Fondsmaeglerselskab A Adma Biologics, Inc. Transaction History
Bi Asset Management Fondsmaeglerselskab A
- $9.48 Billion
- Q4 2024
A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 110,063 shares of ADMA stock, worth $1.78 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
110,063Holding current value
$1.78 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
338Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$301 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$294 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$240 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$183 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$89.5 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.18B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...